OccupationalTherapy.com Phone: 866-782-9924


Scleroderma- An Update

Scleroderma- An Update
Janet Poole, Ph.D., OTR/L, FAOTA
May 2, 2016
Share:

Systemic Sclerosis (SSc)

Systemic sclerosis, or scleroderma, is a progressive multi-system auto-immune disease characterized by thickening of the skin, vascular involvement and fibrosis of the internal organs. The cause is really unknown, but the auto-immune processes result in abnormal collagen build-up. They do not really know what triggers that.

The prevalence is about 240 persons per one million. Both the prevalence and the incidence are 4 times greater in women than in men. The onset is between 30 to 40 years of age, and the average 10 year survival rate is now 70-80%. 

Here are some links to a couple of different websites- The Scleroderma Foundation and NIH. You can also google the Scleroderma Research Foundation. They have a lot of really great information, booklets, and pamphlets for your patients who have scleroderma.

Subtypes of SSc

There are two subsets of scleroderma- limited cutaneous scleroderma and diffuse cutaneous scleroderma.

Limited Cutaneous Scleroderma

In limited systemic sclerosis, there is gradual skin thickening limited to the distal extremities and the face. There is later involvement of the internal organs. The limited sub-type was formerly referred to as CREST Syndrome which was an acronym that described the symptoms typically seen in scleroderma.

  • The 'C' stands for calcinosis. Sub-cutaneous calcium deposits may accumulate most often on the fingers, but also on the forearms, and sometimes on the ischial tuberosities or the lateral malleoli.  Pain and infection may result as the deposits become inflamed.  They can ulcerate and protrude through the skin or extrude white-ish calcific material.
  • 'R' is for Raynaud's phenomenon which is a constriction or narrowing of the blood vessels in response to cold and stress. Severe, untreated Raynaud's may lead to sores and ulcers which can become infected, can heal very slowly or not at all, and can lead to amputations or auto-amputations. Raynaud's phenomenon often one of the first symptoms that people with scleroderma notice.
  • 'E' is for esophageal dysfunction and that can include heartburn, dysphagia, reflux. The motility of the esophagus becomes affected.
  • 'S' is for sclerodactyly. This is the thickening of the skin on the fingers.
  • 'T' is for telangiectasias.  Telangiectasias are dilated blood vessels that are near the surface of the skin. They appear as small red or purple spider-like spots, usually on the fingers, palms, lips, face and tongue. They be a cosmetic problem for some people.

janet poole

Janet Poole, Ph.D., OTR/L, FAOTA

Dr. Poole is a Professor in the Occupational Therapy Graduate Program at the University of New Mexico.  She received her BS degree in Occupational Therapy from Colorado State University, her MA degree in Educational Psychology from the University of North Carolina Chapel Hill and her PhD in motor learning/motor control from the University of Pittsburgh.  Dr. Poole’s research interest is in scleroderma and the functional impact of the disease on tasks of daily living, oral hygiene, parenting and employment.  She has conducted a number of studies examining rehabilitation interventions with people with scleroderma.  Dr. Poole and her colleagues Drs. Khanna and Mendelson received a PCORI grant to revise and test a self-management program for persons with scleroderma.  She speaks yearly at patient conferences for people with scleroderma and has authored several textbook chapters on rehabilitation for persons with scleroderma.



Related Courses

Scleroderma And The OT Role
Presented by Janet Poole, PhD, OTR/L, FAOTA
Video
Course: #5904Level: Introductory1 Hour
Systemic sclerosis (scleroderma) is an autoimmune connective tissue disease affecting the skin, internal organs, and blood vessels. People with scleroderma often develop severe contractures in their hands that make it very difficult to perform daily occupations. This course will review symptoms of scleroderma and the occupational therapist's role. Specific interventions to increase joint motion and manage daily tasks will be presented.

Occupational Therapy: Key To Participation In Daily Life For People With Rheumatic Disease
Presented by Janet Poole, PhD, OTR/L, FAOTA
Video
Course: #5850Level: Intermediate1 Hour
Occupational performance deficits and work disability in people with rheumatic diseases remain high despite advances in medical and pharmacological management Yet, people are often not referred to occupational therapy unless there are hand impairments. This presentation reviews the role and need for occupational therapy in rheumatology care, including interventions to improve hand function, self-management of fatigue, pain, stress and anxiety, and strategies to prevent work disability.

Electrical Stimulation for Recovery of Function in Neurorehabilitation
Presented by Rebecca Martin, OTR/L, OTD, CPAM, CKTP
Video
Course: #3840Level: Intermediate1 Hour
This course will describe the different mechanisms of action for electrical stimulation to restore function in patients with neurological dysfunction. Using case studies and best evidence, participants will learn how to design and execute interventions with electrical stimulation useful in neurorehabiliation.

Joint Hypermobility Syndromes: Assessment and Intervention
Presented by Valeri Calhoun, MS, OTR/L, CHT
Video
Course: #5376Level: Intermediate1 Hour
This course will cover upper extremity assessment and treatment strategies for the pediatric/young adult population affected by joint hypermobility syndromes. The treatment focuses on both orthopedic strategies along with adaptive methods for these individuals.

Disability Inclusion: What Healthcare Providers Need To Know
Presented by Kathryn Sorensen, OTD, OTR/L, ADAC
Video
Course: #5632Level: Introductory1 Hour
As a person with a disability and an occupational therapist, I have a unique perspective of living in two worlds. In this course, I will share my personal experience and things I wish healthcare providers knew and understood about living with a disability.

Our site uses cookies to improve your experience. By using our site, you agree to our Privacy Policy.